A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Wei Shi, Guangdong General Hospital
ClinicalTrials.gov Identifier:
NCT01538433
First received: February 19, 2012
Last updated: August 27, 2013
Last verified: August 2013
  Purpose

This is a survey of factors which affect a pathologically defined early or delayed diagnosis of IgA nephropathy in Guangdong General Hospital, Guangzhou, China. An early or delayed diagnosis of IgA nephropathy is pathologically defined using the recently published Oxford classification of IgA nephropathy. The factors to be surveyed include health examination including urine test, socioeconomic status of patients including education,etc.


Condition
IgA Nephropathy

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy: an Observational Study

Resource links provided by NLM:


Further study details as provided by Guangdong General Hospital:

Primary Outcome Measures:
  • Factors potentially affecting an early or delayed diagnosis of IgA Nephropathy [ Time Frame: Before the biopsy ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Glomerular filtration rate(GFR) decline rate or reaching end-stage renal disease (ESRD) or doubling of serum creatinine [ Time Frame: after the biopsy ] [ Designated as safety issue: No ]

Enrollment: 603
Study Start Date: February 2012
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
biopsy-proven IgA nephropathy

  Eligibility

Ages Eligible for Study:   14 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

The consecutive biopsy-proven IgAN patients in Guangdong General Hospital, Guangzhou,China

Criteria

Inclusion Criteria:

  • biopsy-proven IgA Nephropathy patients in Guangdong General Hospital, Guangzhou,China
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01538433

Locations
China, Guangdong
Nephrology Department,Guangdong General Hospital
Guangzhou, Guangdong, China, 510080
Sponsors and Collaborators
Guangdong General Hospital
Investigators
Principal Investigator: Wei Shi, MD, PhD Guangdong General Hospital
  More Information

No publications provided

Responsible Party: Wei Shi, Prof., Guangdong General Hospital
ClinicalTrials.gov Identifier: NCT01538433     History of Changes
Other Study ID Numbers: GGH201107
Study First Received: February 19, 2012
Last Updated: August 27, 2013
Health Authority: China: Ethics Committee

Keywords provided by Guangdong General Hospital:
diagnosis
IgA nephropathy

Additional relevant MeSH terms:
Glomerulonephritis, IGA
Kidney Diseases
Glomerulonephritis
Nephritis
Urologic Diseases
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on August 26, 2014